Compare Amphastar Pharmaceuticals Inc (AMPH) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Energy Select Sector SPDR Fund — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Energy Select Sector SPDR Fund trades at $60.91. The key difference: Energy Select Sector SPDR Fund is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | XLE | |
|---|---|---|
Market Cap | $863.95M | — |
Sector | Health | — |
52-Week High | $30.81 | $62.57 |
52-Week Low | $16.87 | $42.12 |
Enterprise Value | $1.26B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
XLE (Energy Select Sector SPDR ETF) trades at $57.48, down 1.17% amid bearish technical signals. The ETF faces headwinds despite strong energy sector performance driven by geopolitical tensions and elevated oil prices. Recent earnings from major holdings like ExxonMobil and Chevron showed profit surges, but technical indicators suggest near-term weakness with resistance at $58 and support at $57.
Outlook remains mixed with geopolitical risks supporting oil prices but technical weakness suggesting caution. The concentrated exposure to major energy companies provides stability but limits diversification. Key risks include oil price volatility and Middle East tensions, while the low expense ratio of 0.08% maintains cost efficiency for long-term energy exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
